“Recombinant Human Erythropoietin (rHuEPO) Reduces Transfusion Requirements in Anaemia of Prematurity”. 2015. Northern International Medical College Journal 6 (2): 53-56. https://doi.org/10.3329/nimcj.v6i2.23171.